Phase I Study of the Maternal Single-Dose Pharmacokinetics and Placental Transfer of Tenofovir 1% Vaginal Gel Among Healthy Term Gravidas.

Trial Profile

Phase I Study of the Maternal Single-Dose Pharmacokinetics and Placental Transfer of Tenofovir 1% Vaginal Gel Among Healthy Term Gravidas.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Oct 2016

At a glance

  • Drugs Tenofovir (Primary)
  • Indications HIV infections; Pregnancy
  • Focus Pharmacokinetics
  • Most Recent Events

    • 26 Mar 2012 Actual end date Jan 2010 added as reported by ClinicalTrials.gov.
    • 26 Mar 2012 Actual end date Jan 2010 added as reported by ClinicalTrials.gov.
    • 26 Mar 2012 Actual patient number 21 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top